Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 19

1.

Amoxicillin-Clavulanate-Induced Liver Injury.

deLemos AS, Ghabril M, Rockey DC, Gu J, Barnhart HX, Fontana RJ, Kleiner DE, Bonkovsky HL; Drug-Induced Liver Injury Network (DILIN).

Dig Dis Sci. 2016 Mar 22. [Epub ahead of print]

PMID:
27003146
2.

Febuxostat-induced acute liver injury.

Bohm M, Vuppalanchi R, Chalasani N; Drug-Induced Liver Injury Network (DILIN).

Hepatology. 2016 Mar;63(3):1047-9. doi: 10.1002/hep.28403. Epub 2016 Feb 3. No abstract available.

PMID:
26679098
3.

Liver injury from nonsteroidal anti-inflammatory drugs in the United States.

Schmeltzer PA, Kosinski AS, Kleiner DE, Hoofnagle JH, Stolz A, Fontana RJ, Russo MW; Drug-Induced Liver Injury Network (DILIN).

Liver Int. 2016 Apr;36(4):603-9. doi: 10.1111/liv.13032. Epub 2015 Dec 15.

PMID:
26601797
4.

Prevalence of genetic variants of keratins 8 and 18 in patients with drug-induced liver injury.

Usachov V, Urban TJ, Fontana RJ, Gross A, Iyer S, Omary MB, Strnad P; Drug-Induced Liver Injury Network.

BMC Med. 2015 Aug 19;13:196. doi: 10.1186/s12916-015-0418-0.

5.

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, Watkins PB, Navarro V, Barnhart H, Gu J, Serrano J; United States Drug Induced Liver Injury Network.

Gastroenterology. 2015 Jun;148(7):1340-52.e7. doi: 10.1053/j.gastro.2015.03.006. Epub 2015 Mar 6.

PMID:
25754159
6.

Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity.

Hayashi PH, Fontana RJ, Chalasani NP, Stolz AA, Talwalkar JA, Navarro VJ, Lee WM, Davern TJ, Kleiner DE, Gu J, Hoofnagle JH; US Drug-Induced Liver Injury Network Investigators.

Clin Gastroenterol Hepatol. 2015 Sep;13(9):1676-82.e1. doi: 10.1016/j.cgh.2015.02.024. Epub 2015 Feb 24.

7.

Herbal dietary supplement associated hepatotoxicity: an upcoming workshop and need for research.

Vuppalanchi R, Navarro V, Vega M, Bonkovsky HL, Seeff L, Serrano J; Drug-Induced Liver Injury Network (DILIN).

Gastroenterology. 2015 Mar;148(3):480-2. doi: 10.1053/j.gastro.2015.01.004. Epub 2015 Jan 8. No abstract available.

8.

Identification and Characterization of Cefazolin-Induced Liver Injury.

Alqahtani SA, Kleiner DE, Ghabril M, Gu J, Hoofnagle JH, Rockey DC; Drug-Induced Liver Injury Network (DILIN) Study Investigators.

Clin Gastroenterol Hepatol. 2015 Jul;13(7):1328-1336.e2. doi: 10.1016/j.cgh.2014.11.036. Epub 2014 Dec 18.

PMID:
25528012
9.

Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.

Kleiner DE, Chalasani NP, Lee WM, Fontana RJ, Bonkovsky HL, Watkins PB, Hayashi PH, Davern TJ, Navarro V, Reddy R, Talwalkar JA, Stolz A, Gu J, Barnhart H, Hoofnagle JH; Drug-Induced Liver Injury Network (DILIN).

Hepatology. 2014 Feb;59(2):661-70. doi: 10.1002/hep.26709. Epub 2013 Dec 18.

10.

Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.

Ghabril M, Bonkovsky HL, Kum C, Davern T, Hayashi PH, Kleiner DE, Serrano J, Rochon J, Fontana RJ, Bonacini M; US Drug-Induced Liver Injury Network.

Clin Gastroenterol Hepatol. 2013 May;11(5):558-564.e3. doi: 10.1016/j.cgh.2012.12.025. Epub 2013 Jan 17. Review.

11.

Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.

Urban TJ, Shen Y, Stolz A, Chalasani N, Fontana RJ, Rochon J, Ge D, Shianna KV, Daly AK, Lucena MI, Nelson MR, Molokhia M, Aithal GP, Floratos A, Pe'er I, Serrano J, Bonkovsky H, Davern TJ, Lee WM, Navarro VJ, Talwalkar JA, Goldstein DB, Watkins PB; Drug-Induced Liver Injury Network; DILIGEN; EUDRAGENE; Spanish DILI Registry; International Serious Adverse Events Consortium.

Pharmacogenet Genomics. 2012 Nov;22(11):784-95. doi: 10.1097/FPC.0b013e3283589a76.

12.

Serum proteomic profiling in patients with drug-induced liver injury.

Bell LN, Vuppalanchi R, Watkins PB, Bonkovsky HL, Serrano J, Fontana RJ, Wang M, Rochon J, Chalasani N; US Drug-Induced Liver Injury Network (DILIN) Research Group.

Aliment Pharmacol Ther. 2012 Mar;35(5):600-12.

13.

Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury.

Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, Engle RE, Nguyen H, Emerson SU, Purcell RH, Tillmann HL, Gu J, Serrano J, Hoofnagle JH; Drug-Induced Liver Injury Network (DILIN).

Gastroenterology. 2011 Nov;141(5):1665-72.e1-9. doi: 10.1053/j.gastro.2011.07.051. Epub 2011 Aug 16.

14.

Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.

Molleston JP, Fontana RJ, Lopez MJ, Kleiner DE, Gu J, Chalasani N; Drug-Induced Liver Injury Network.

J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):182-9. doi: 10.1097/MPG.0b013e31821d6cfd.

15.

Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network.

Vuppalanchi R, Hayashi PH, Chalasani N, Fontana RJ, Bonkovsky H, Saxena R, Kleiner D, Hoofnagle JH; Drug-Induced Liver Injury Network (DILIN).

Aliment Pharmacol Ther. 2010 Nov;32(9):1174-83. doi: 10.1111/j.1365-2036.2010.04449.x. Epub 2010 Sep 3.

16.

Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.

Rockey DC, Seeff LB, Rochon J, Freston J, Chalasani N, Bonacini M, Fontana RJ, Hayashi PH; US Drug-Induced Liver Injury Network.

Hepatology. 2010 Jun;51(6):2117-26. doi: 10.1002/hep.23577.

17.

Important elements for the diagnosis of drug-induced liver injury.

Agarwal VK, McHutchison JG, Hoofnagle JH; Drug-Induced Liver Injury Network.

Clin Gastroenterol Hepatol. 2010 May;8(5):463-70. doi: 10.1016/j.cgh.2010.02.008. Epub 2010 Feb 17. Review.

18.

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J; Drug Induced Liver Injury Network (DILIN).

Gastroenterology. 2008 Dec;135(6):1924-34, 1934.e1-4. doi: 10.1053/j.gastro.2008.09.011. Epub 2008 Sep 17.

19.

Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury.

Rochon J, Protiva P, Seeff LB, Fontana RJ, Liangpunsakul S, Watkins PB, Davern T, McHutchison JG; Drug-Induced Liver Injury Network (DILIN).

Hepatology. 2008 Oct;48(4):1175-83. doi: 10.1002/hep.22442.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk